Global Infectious Disease In vitro Diagnostics Market (2024 Edition): Analysis By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other Technologies), By Product Type, By End User, By Region, By Country: Market Insights and Forecast (2020-20

Global Infectious Disease In vitro Diagnostics Market (2024 Edition): Analysis By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other Technologies), By Product Type, By End User, By Region, By Country: Market Insights and Forecast (2020-2030)

Executive Summary

Azoth Analytics has released a research report titled “Global Infectious Disease In vitro Diagnostics Market (2024 Edition)” which provides a complete analysis of the Global Infectious Disease In vitro Diagnostics industry in terms of market segmentation By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other Technologies), By Product Type (Instruments, Reagents, and Services) By End Users (Point of care, Central Laboratories, Other End-users) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Global Infectious Disease In vitro Diagnostics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The Global Infectious Disease In vitro Diagnostics Market showcased growth at a CAGR of 2.45 % during 2020-2023. The market was valued at USD 65.86 Billion in 2023 which is expected to reach USD 80.31 Billion in 2030.

The global market for infectious disease in-vitro diagnostics encompasses a wide range of diagnostic tests and technologies used for the detection and management of infectious diseases. It

includes various assays, instruments, and reagents designed to identify pathogens, such as bacteria, viruses, fungi, and parasites, responsible for causing infectious illnesses in humans.

These diagnostic tools play a crucial role in disease surveillance, outbreak control, patient management, and public health interventions worldwide.

The market for infectious disease in-vitro diagnostics is driven by several factors, including the increasing prevalence of infectious diseases, rising demand for rapid and accurate diagnostic solutions, advancements in diagnostic techno*logies, and growing awareness about the importance of early disease detection and intervention. Additionally, factors such as globalization, urbanization, population growth, and environmental changes contribute to the spread of infectious pathogens, further fueling the demand for diagnostic tests and tools.

The market is characterized by intense competition among key players, including diagnostic manufacturers, biotechnology companies, and healthcare organizations. These companies are

continuously innovating and launching new products and solutions to meet the evolving needs of healthcare providers, laboratories, and patients.

Scope of the Report:

• The report analyses the Global Infectious Disease In vitro Diagnostics Market by Value (USD Billion).
• The report presents the analysis of Global Infectious Disease In vitro Diagnostics Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
• The report analyses the Global Infectious Disease In vitro Diagnostics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
• The report analyses the Global Infectious Disease In vitro Diagnostics Market By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other Technologies)
• The report analyses the Global Infectious Disease In vitro Diagnostics Market By Product Type (Instruments, Reagents, and Services).
• The report analyses the Global Infectious Disease In vitro Diagnostics Market By End Users (Point of care, Central Laboratories, and Other End Uses).
• The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Technology, By Product Type and By End User.
• Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include QIAGEN, F. Hoffmann-La Roche AG, OraSure technologies, PerkinElmer Inc., Abbott Laboratories, Thermo Fisher, Becton, Dickinson and Company, Hologic, Inc., Danaher Corporation, and Bio-Rad Laboratories